Active Ingredient(s): Aliskiren + Amlodipine
FDA Approved: * August 26, 2010
Pharm Company: * NOVARTIS PHARMS
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Tekamlo Overview

The drug combination aliskiren/amlodipine (INNs, trade names Tekamlo and Rasilamlo) is an antihypertensive. Clinical trials have shown it to be more effective than amlodipine on its own,[1] with a high dosing regime (aliskiren 300mg/amlodipine 10mg) being more effective than olmesartan/amlodipine with comparable tolerability.[2] References .mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .referen...

Read more Tekamlo Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Aliskiren/amlodipine

Recent Tekamlo Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Aliskiren + Amlodipine
  • Tablet: 150mg + 10mg, 150mg + 5mg, 300mg + 10mg, 300mg + 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Tekamlo: (4 results)

Sorted by National Drug Code
  • 0078-0603 Tekamlo 150/5 (Aliskiren / Amlodipine) Oral Tablet by Novartis Pharmaceuticals Corporation
  • 0078-0604 Tekamlo 150/10 (Aliskiren / Amlodipine) Oral Tablet by Novartis Pharmaceuticals Corporation
  • 0078-0605 Tekamlo 300/5 (Aliskiren / Amlodipine) Oral Tablet by Novartis Pharmaceuticals Corporation
  • 0078-0606 Tekamlo 300/10 (Aliskiren / Amlodipine) Oral Tablet by Novartis Pharmaceuticals Corporation

Drugs with one or more similar ingredients: (33 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 April 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA